Although the MAC can directly lyse tumor cells by disrupting membrane integrity (119), CRC cells evade complement-mediated cytotoxicity by upregulating CRPs such as CD55, CD46, and CD59 via STAT3/STAT6/p38 MAPK signaling (44, 107, 120, 121). The gene discussed is CD59; the disease is neoplasm.